On the one hand, increasing international competition is forcing companies to optimize their manufacturing and R&D processes. These trends increase quality and efficiency demands especially for the processing of oral solid dose forms as the predominant galenic form. This includes the important step of tablet coating at the end of the process. On the other hand, there are few options to obtain a perfect mix of theoretical and practical training. We want to bridge this gap between business...
An innovative tablet coating formulation capable of reducing coating process time, energy and cost while maximizing the potential of continuous and batch coaters of any size, is certain to take center stage. INSTACOAT 4G stands today as a finalist for the CPhI Pharma Excellence Awards 2017 – Excipient Category. Visit the Ideal Cures team at our Booth 102B91 from 24th -26th October 2017 to understand how this formulation can help you earn carbon credits and double your production output.